Production Capacity
In its state-of-the-art privately owned factory, with an area of 12,000 m2, in Pallini Attica, it houses two separate advanced production lines, designed according to all European specifications (EU GMPs). Each one specializes in the production of conventional and oncological solids.
Conventional: 600M tablets, 40M capsules
Oncology: 130M tablets, 10M capsules
Therapeutic Areas
Global Presence
While GENEPHARM is systematically strengthening its position in the domestic market, having established solid relationships with Greek physicians and patients, our business expands lobally through strategic alliances, based on the development of new products and continuous investment in advanced infrastructure and technologies.
Today, our presence extends to more than 90 countries, through our collaboration with some of the most well-known pharmaceutical companies in the world.
